We serve Chemical Name:(1S)-2,2,2-Trifluoro-1-(4-fluorophenyl)ethanamine hydrochloride ( 1:1) CAS:929642-58-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(1S)-2,2,2-Trifluoro-1-(4-fluorophenyl)ethanamine hydrochloride ( 1:1)
CAS.NO:929642-58-0
Synonyms:(1S)-2,2,2-Trifluoro-1-(4-fluorophenyl)ethanamine hydrochloride ( 1:1)
Molecular Formula:C8H8ClF4N
Molecular Weight:229.60200
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:26.02000
Exact Mass:229.02800
LogP:3.89010
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like (1S)-2,2,2-Trifluoro-1-(4-fluorophenyl)ethanamine hydrochloride ( 1:1) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(1S)-2,2,2-Trifluoro-1-(4-fluorophenyl)ethanamine hydrochloride ( 1:1) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(1S)-2,2,2-Trifluoro-1-(4-fluorophenyl)ethanamine hydrochloride ( 1:1) Use and application,(1S)-2,2,2-Trifluoro-1-(4-fluorophenyl)ethanamine hydrochloride ( 1:1) technical grade,usp/ep/jp grade.
Related News: “The synergies among our Regulatory, Clinical and Real-World Evidence (RWE) practices and CROS NT’s global biometrics capabilities will enhance Alira Health’s unique ability to serve clients across their solutions lifecycle,” said CEO Gabriele Brambilla in a statement. (1S)-2,2,2-Trifluoro-1-(4-fluorophenyl)ethanamine hydrochloride ( 1:1) manufacturer The insulin-only and bihormonal configurations may be helpful in diabetes. (1S)-2,2,2-Trifluoro-1-(4-fluorophenyl)ethanamine hydrochloride ( 1:1) supplier The results of analysis perfectly align with the tau hypothesis — simply put, if the patient is tau biomarker positive, then tau pathology is responsible for his/her cognitive decline, and halting tau pathology should slow or halt progression,” Novak said. “If the patient is negative for markers of tau pathology, then this patient’s impairment is mainly due to other pathologies, and treating tau pathology in this patient won’t be meaningful. (1S)-2,2,2-Trifluoro-1-(4-fluorophenyl)ethanamine hydrochloride ( 1:1) vendor “The synergies among our Regulatory, Clinical and Real-World Evidence (RWE) practices and CROS NT’s global biometrics capabilities will enhance Alira Health’s unique ability to serve clients across their solutions lifecycle,” said CEO Gabriele Brambilla in a statement. (1S)-2,2,2-Trifluoro-1-(4-fluorophenyl)ethanamine hydrochloride ( 1:1) factory The insulin-only and bihormonal configurations may be helpful in diabetes.
